Analyst Ratings for HCA Healthcare Inc (HCA)
HCA Rating Summary
HCA Price Target Summary
- Highest: $635.00 (UBS)
- Lowest: $396.00 (Baird)
- Average: $492.10
* Over Last 12-Mos
Overall Rating:
BUY
Rating Trend:
Avg. $ Target:
$492.10 (+32.6%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
Avg. $ Target:
$492.10 (+32.6%)
* Over Last 12-Mos
Rating Score: 6.4 / 10
Percentile Rank: 67%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 7/8/2026 | Barclays » Updated 7/16/2026 |
Andrew Mok | Downgrade | Equalweight (Overweight) |
402.00 (427.00) |
423.11 (371.18) |
-12.27% | Details |
| 12/15/2025 | Morgan Stanley | Craig Hettenbach | Downgrade | Underweight (Equalweight) |
425.00 (N/A) |
482.35 (371.18) |
-23.05% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
